Gouni-Berthold I

ORCID: 0000-0001-9455-1636 · 2 papers in corpus
2024
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph17070913

Lipid-lowering therapy (LLT) is a cornerstone of atherosclerotic cardiovascular disease prevention. Although LLT might lead to different reductions in low-density lipoprotein cholesterol (LDL-C) levels in women and men, LLT diminishes cardi…

2024
Deutsches Arzteblatt international ·doi:10.3238/arztebl.m2024.0063

BackgroundCardiovascular diseases due to arteriosclerosis are the most common causes of death and disability in both men and women. Hypercholesterolemia, a treatable risk factor, is often detected after a delay in women, and then inadequate…